← Leaderboards
Emmanuel Zorn
Columbia University Health Sciences
$13,388,322
Attributed
$13,388,322
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,388,322 · 11
By mechanism
R01$7,388,745 · 4
U01$3,138,288 · 1
R56$1,516,539 · 3
R21$1,344,750 · 3
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Muredach P Reilly$136,077,018
- Milton Packer$29,058,211
- Megan Sykes$56,546,810
- Benjamin Tycko$19,558,566
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsB-LymphocytesAntibodiesBaseBloodImmunitySpecimenImmunoglobulin GSamplingResponsePhenotypeAntigensApoptoticPreventSeriesComplicationFunctional DisorderImmuneClone CellsTransplant RecipientsIn VitroHumoral ImmunitiesSourceFlow Cytometry
Grant awards (35)
Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy$761,840
R01 · FY2025 · AI · contact PI
Antibody responses to chemical adducts in human kidney allograft rejection$526,658
R01 · FY2025 · AI · contact PI
Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy$642,056
R56 · FY2024 · AI · contact PI
Thymic plasma cells as a source of protective natural antibodies in human neonates$205,625
R21 · FY2024 · AI · contact PI
Source and homeostatic functions of anti-adduct IgM in humans$205,625
R21 · FY2024 · AI · contact PI
Thymic plasma cells as a source of protective natural antibodies in human neonates$246,750
R21 · FY2023 · AI · contact PI
Source and homeostatic functions of anti-adduct IgM in humans$246,750
R21 · FY2023 · AI · contact PI
Local antibody responses in human cardiac allograft vasculopathy$542,608
R56 · FY2021 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$467,000
U01 · FY2021 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$394,144
U01 · FY2021 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$467,000
U01 · FY2020 · AI · contact PI
Innate B cell immunity and antibody-mediated rejection of human kidney allografts$441,645
R01 · FY2020 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$394,144
U01 · FY2020 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$467,000
U01 · FY2019 · AI · contact PI
Innate B cell immunity and antibody-mediated rejection of human kidney allografts$441,645
R01 · FY2019 · AI · contact PI
Contribution of B cells to human cardiac allograft vasculopathy$402,450
R01 · FY2019 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$467,000
U01 · FY2018 · AI · contact PI
Innate B cell immunity and antibody-mediated rejection of human kidney allografts$441,645
R01 · FY2018 · AI · contact PI
Contribution of B cells to human cardiac allograft vasculopathy$402,450
R01 · FY2018 · AI · contact PI
Development and significance of the plasma cell niche in the human infant thymus$482,000
U01 · FY2017 · AI · contact PI
Innate B cell immunity and antibody-mediated rejection of human kidney allografts$443,535
R01 · FY2017 · AI · contact PI
Contribution of B cells to human cardiac allograft vasculopathy$402,450
R01 · FY2017 · AI · contact PI
Innate B cell immunity and antibody-mediated rejection of human kidney allografts$454,755
R01 · FY2016 · AI · contact PI
Contribution of B cells to human cardiac allograft vasculopathy$402,450
R01 · FY2016 · AI · contact PI
Contribution of B cells to human cardiac allograft vasculopathy$216,062
R01 · FY2015 · AI · contact PI
The human innate B cell niche and role in efferocytosis$200,000
R21 · FY2015 · AI · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$292,470
R01 · FY2014 · DK · contact PI
The human innate B cell niche and role in efferocytosis$240,000
R21 · FY2014 · AI · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$94,540
R01 · FY2014 · DK · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$445,446
R01 · FY2013 · DK · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$363,602
R01 · FY2012 · DK · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$49,000
R01 · FY2012 · DK · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$363,602
R01 · FY2011 · DK · contact PI
Characterization of B cells infiltrating human kidney grafts during rejection$331,875
R56 · FY2011 · AI · contact PI
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in Humans$442,500
R01 · FY2010 · DK · contact PI